日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The epigenetic hallmarks of immune cells in cancer

癌症中免疫细胞的表观遗传学特征

Ji, Yu; Xiao, Chu; Fan, Tao; Deng, Ziqin; Wang, Di; Cai, Wenpeng; Li, Jia; Liao, Tianle; Li, Chunxiang; He, Jie

SLAMF receptors: key regulators of tumor progression and emerging targets for cancer immunotherapy

SLAMF受体:肿瘤进展的关键调控因子和癌症免疫治疗的新兴靶点

Li, Jia; Fan, Tao; Wang, Di; Xiao, Chu; Deng, Ziqin; Cai, Wenpeng; Ji, Yu; Li, Chunxiang; He, Jie

Neutrophils in cancer: At the crucial crossroads of anti-tumor and pro-tumor

癌症中的中性粒细胞:处于抗肿瘤和促肿瘤的关键十字路口

Cai, Wenpeng; Fan, Tao; Xiao, Chu; Deng, Ziqin; Liu, Yixiao; Li, Chunxiang; He, Jie

Signatures of H3K4me3 modification predict cancer immunotherapy response and identify a new immune checkpoint-SLAMF9.

H3K4me3 修饰的特征可以预测癌症免疫疗法的反应,并识别出一个新的免疫检查点——SLAMF9

Fan Tao, Xiao Chu, Deng Ziqin, Li Shuofeng, Tian He, Zheng Yujia, Zheng Bo, Li Chunxiang, He Jie

TGF-β signaling in health, disease, and therapeutics

TGF-β信号在健康、疾病和治疗中的作用

Deng, Ziqin; Fan, Tao; Xiao, Chu; Tian, He; Zheng, Yujia; Li, Chunxiang; He, Jie

H3K4 trimethylation regulates cancer immunity: a promising therapeutic target in combination with immunotherapy

H3K4三甲基化调控癌症免疫:一种有前景的免疫疗法联合治疗靶点

Xiao, Chu; Fan, Tao; Zheng, Yujia; Tian, He; Deng, Ziqin; Liu, Jingjing; Li, Chunxiang; He, Jie

Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy

肿瘤微环境中的糖酵解作为改善癌症免疫疗法的靶点

Xiao, Chu; Tian, He; Zheng, Yujia; Yang, Zhenlin; Li, Shuofeng; Fan, Tao; Xu, Jiachen; Bai, Guangyu; Liu, Jingjing; Deng, Ziqin; Li, Chunxiang; He, Jie

Bibliometric and Visualization Analysis of Human Coronaviruses: Prospects and Implications for COVID-19 Research

人类冠状病毒的文献计量学和可视化分析:对 COVID-19 研究的前景和启示

Deng, Ziqin; Chen, Junsheng; Wang, Ting